Janssen Korea intensifies effort to boost sales

Janssen Korea said recently that it would launch Velcade (bortezomib) injection, a new treatment for multiple myeloma, a cancer of the bone marrow, within this year in addition to Sporanox (itraconazole) for the treatment of fungal infections and Durogesic for the management of chronic intractable pain that requires opioid analgesia which cannot be managed by lesser means.

Velcade is the fir...